Adipotide vs AOD-9604

Name: Adipotide vs AOD-9604
Published: 2026-10-24

Updated Oct 24, 20266 sources

Key differences

1Different molecules. AOD-9604 is a growth-hormone fragment studied for fat breakdown; adipotide is a fat-vessel-targeting peptide with a cell-killing tail.
2AOD-9604 has human trial history; adipotide has one terminated trial with no results.

Facts from each record, in the same words as their own pages.

Adipotide and AOD-9604 side by side
	Adipotide	AOD-9604
Category	Weight loss	Weight loss
Evidence	Animal data only	Limited human data
FDA status	Not FDA approvedRegulatory	Not FDA approvedRegulatory
WADA	Not confirmed	Prohibited
Half-life	Not reported	About 3 minutes after an IV bolus in pigs and about 4 minutes in rat blood in vitro. No human subcutaneous data.Clinical study
Routes	Subcutaneous injection	Oral, Subcutaneous injection
Forms	Vial (powder)	Not reported
Reported doses	0.03 to 0.07 mg/kg (subcutaneous injection) 250 to 1,000 mcg (subcutaneous injection) 0.1 to 5 mg (subcutaneous injection)	0.25 to 30 mg (oral) 250 to 500 mcg (subcutaneous injection) 1 to 2 mg (subcutaneous injection)
Most cited frequency	Once daily	Once daily
Vial sizes	1 mg, 2 mg, 5 mg, 10 mgCompetitor guide	2 mg, 5 mg, 10 mgCompetitor guide
Mixed vial keeps	Fridge at 2 to 8 °C, protected from light, no freeze-thaw.Competitor guide	Keep at 2 to 8 °C, away from light, and do not freeze and thaw.Community-reported
Protocols on file	7	12

Doses shown are what sources report, labelled by origin. Not medical advice.

6 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.